CDNA - CareDx, Inc
NASDAQ
->
Healthcare
->
Diagnostics & Research
South San Francisco,
United States
Type: Equity
CDNA price evolution
CDNA
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $82.78 | $76.56 | $88.37 | $75.18 |
| Short term investments | $153.22 | $192.2 | $194.89 | $211.28 |
| Net receivables | $51.06 | $51.69 | $51.63 | $59.31 |
| Inventory | $19.47 | $17.98 | $18.84 | $18.02 |
| Total current assets | $313.71 | $345.17 | $360.81 | $371.43 |
| Long term investments | ||||
| Property, plant & equipment | $65.14 | $66.33 | $68.2 | $68.94 |
| Goodwill & intangible assets | $86.04 | $86.66 | $83.18 | $85.25 |
| Total noncurrent assets | $153.11 | $156.01 | $154.01 | $156.79 |
| Total investments | $153.22 | $192.2 | $194.89 | $211.28 |
| Total assets | $466.83 | $501.18 | $514.82 | $528.22 |
| Current liabilities | ||||
| Accounts payable | $12.87 | $8.97 | $9.88 | $12.86 |
| Deferred revenue | $2.46 | $4.74 | $4.22 | $4.09 |
| Short long term debt | ||||
| Total current liabilities | $78.07 | $72.67 | $74.5 | $71.83 |
| Long term debt | $28.28 | $29.25 | $30.59 | $32.01 |
| Total noncurrent liabilities | $127.43 | $34.37 | $35.11 | $36.37 |
| Total debt | $28.28 | $29.25 | $30.59 | $32.01 |
| Total liabilities | $205.5 | $107.05 | $109.61 | $108.2 |
| Shareholders' equity | ||||
| Retained earnings | -$678.27 | -$534.2 | -$509.9 | -$484.88 |
| Other shareholder equity | -$6.96 | -$8.67 | -$8.45 | -$7.44 |
| Total shareholder equity | $261.33 | $394.13 | $405.21 | $420.02 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $82.78 | $90.44 | $348.7 | $134.94 |
| Short term investments | $153.22 | $203.17 | $90.03 | |
| Net receivables | $51.06 | $66.31 | $59.76 | $34.62 |
| Inventory | $19.47 | $19.23 | $17.19 | $10.01 |
| Total current assets | $313.71 | $387.85 | $433.36 | $273.1 |
| Long term investments | ||||
| Property, plant & equipment | $65.14 | $70.22 | $40.04 | $25.93 |
| Goodwill & intangible assets | $86.04 | $80.57 | $87.18 | $68.21 |
| Total noncurrent assets | $153.11 | $155.14 | $133.26 | $95.41 |
| Total investments | $153.22 | $203.17 | $90.03 | |
| Total assets | $466.83 | $542.99 | $566.62 | $368.51 |
| Current liabilities | ||||
| Accounts payable | $12.87 | $9.94 | $13.34 | $9.65 |
| Deferred revenue | $2.46 | $2.42 | $5.04 | $3.56 |
| Short long term debt | ||||
| Total current liabilities | $78.07 | $75.97 | $77.3 | $69.22 |
| Long term debt | $28.28 | $33.41 | $17.39 | $16.07 |
| Total noncurrent liabilities | $127.43 | $36.1 | $23.44 | $21.61 |
| Total debt | $28.28 | $33.41 | $17.39 | $16.07 |
| Total liabilities | $205.5 | $112.08 | $100.75 | $90.83 |
| Shareholders' equity | ||||
| Retained earnings | -$678.27 | -$460.44 | -$383.19 | -$352.53 |
| Other shareholder equity | -$6.96 | -$7.5 | -$4.67 | -$2.1 |
| Total shareholder equity | $261.33 | $430.91 | $465.88 | $277.68 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $65.57 | $67.19 | $70.3 | $77.26 |
| Cost of revenue | $25.61 | $24.53 | $25.89 | $25.97 |
| Gross Profit | $39.96 | $42.66 | $44.41 | $51.3 |
| Operating activities | ||||
| Research & development | $18.28 | $19 | $20.23 | $24.36 |
| Selling, general & administrative | $46.54 | $52.44 | $50.96 | $51.26 |
| Total operating expenses | $162.59 | $71.44 | $72.04 | $75.62 |
| Operating income | -$122.63 | -$28.78 | -$27.62 | -$24.32 |
| Income from continuing operations | ||||
| EBIT | -$121.09 | -$26.74 | -$27.89 | -$26.29 |
| Income tax expense | $0.17 | -$0.08 | -$0.07 | $0.12 |
| Interest expense | -$3.16 | -$3.17 | -$2.87 | -$2.67 |
| Net income | ||||
| Net income | -$118.1 | -$23.48 | -$24.95 | -$23.75 |
| Income (for common shares) | -$118.1 | -$23.48 | -$24.95 | -$23.75 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $280.32 | $321.79 | $296.4 | $192.19 |
| Cost of revenue | $102 | $112.21 | $97.39 | $63.12 |
| Gross Profit | $178.32 | $209.58 | $199.01 | $129.08 |
| Operating activities | ||||
| Research & development | $81.87 | $90.39 | $76.53 | $48.94 |
| Selling, general & administrative | $201.2 | $196.42 | $152.21 | $102.66 |
| Total operating expenses | $381.69 | $286.81 | $228.73 | $151.6 |
| Operating income | -$203.36 | -$77.23 | -$29.73 | -$22.53 |
| Income from continuing operations | ||||
| EBIT | -$202.01 | -$80 | -$32.25 | -$20.02 |
| Income tax expense | $0.14 | $0.38 | -$1.43 | -$1.04 |
| Interest expense | -$11.87 | -$3.76 | -$0.16 | -$0.27 |
| Net income | ||||
| Net income | -$190.28 | -$76.61 | -$30.66 | -$18.71 |
| Income (for common shares) | -$190.28 | -$76.61 | -$30.66 | -$18.71 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$118.1 | -$23.48 | -$24.95 | -$23.75 |
| Operating activities | ||||
| Depreciation | $5.05 | $5.03 | $4.98 | $4.76 |
| Business acquisitions & disposals | -$2.12 | -$4.56 | ||
| Stock-based compensation | $9.96 | $12.67 | $12.7 | $13.75 |
| Total cash flows from operations | -$8.38 | -$10.18 | -$0.5 | $0.67 |
| Investing activities | ||||
| Capital expenditures | -$0.7 | -$2.51 | -$2.36 | -$2.77 |
| Investments | $42.96 | $3.13 | $17.71 | -$7.44 |
| Total cash flows from investing | $41.37 | -$1.5 | $15.35 | -$14.77 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$25.96 | $0.33 | -$0.06 | -$0.23 |
| Net borrowings | ||||
| Total cash flows from financing | -$26.88 | -$0.03 | -$1.57 | -$1.14 |
| Effect of exchange rate | $0.11 | -$0.11 | -$0.09 | -$0.03 |
| Change in cash and equivalents | $6.22 | -$11.81 | $13.19 | -$15.26 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$190.28 | -$76.61 | -$30.66 | -$18.71 |
| Operating activities | ||||
| Depreciation | $19.82 | $16.01 | $11.88 | $9.54 |
| Business acquisitions & disposals | -$6.68 | -$0.61 | -$15.43 | |
| Stock-based compensation | $49.09 | $46.55 | $36.08 | $23.4 |
| Total cash flows from operations | -$18.39 | -$25.24 | -$19.29 | $33.43 |
| Investing activities | ||||
| Capital expenditures | -$8.34 | -$21.23 | -$13.56 | -$7.11 |
| Investments | $56.37 | -$203.56 | $83.41 | -$90.03 |
| Total cash flows from investing | $40.45 | -$228.5 | $47.71 | -$100.39 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$25.92 | $4.02 | $203.77 | $167.86 |
| Net borrowings | -$0.07 | -$0.18 | ||
| Total cash flows from financing | -$29.61 | -$4.54 | $185.64 | $163.15 |
| Effect of exchange rate | -$0.11 | $0.02 | -$0.3 | $0.27 |
| Change in cash and equivalents | -$7.66 | -$258.25 | $213.76 | $96.46 |
News
Fundamentals
| Market cap | $763.80M |
|---|---|
| Enterprise value | $709.29M |
| Shares outstanding | 51.50M |
| Revenue | $280.32M |
|---|---|
| EBITDA | -$182.19M |
| EBIT | -$202.01M |
| Net Income | -$190.28M |
| Revenue Q/Q | -20.41% |
| Revenue Y/Y | -12.89% |
| P/E ratio | -4.01 |
|---|---|
| EV/Sales | 2.53 |
| EV/EBITDA | -3.89 |
| EV/EBIT | -3.51 |
| P/S ratio | 2.72 |
| P/B ratio | 2.85 |
| Book/Share | 5.21 |
| Cash/Share | 1.61 |
| EPS | -$3.69 |
|---|---|
| ROA | -37.85% |
| ROE | -51.40% |
| Debt/Equity | 0.79 |
|---|---|
| Net debt/EBITDA | -0.67 |
| Current ratio | 4.02 |
| Quick ratio | 3.77 |